Publication | Open Access
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study
24
Citations
25
References
2021
Year
SINE compounds enhance the activity of CHO <i>in vitro</i> and <i>in vivo</i>. Selinexor in combination with R-CHOP was generally well tolerated and showed encouraging efficacy in NHL (NCT03147885).
| Year | Citations | |
|---|---|---|
Page 1
Page 1